Assistant Professor of Pathology, Director, Molecular Virology, Johns Hopkins Medicine
Biography
Dr. Heba Mostafa completed her M.D. at the Faculty of Medicine, Alexandria University, Egypt in 2004 which was followed by a period of training and residency in clinical pathology. After completion of her M.D., she moved to the United States where she earned her Ph.D. in Microbiology in 2014 at the University of Kansas. In the 3 years following, she completed a Post-Doctoral Research Fellowship at St. Jude Children's Research Hospital where she focused on studying the pathogenesis, spread, and clearance of parainfluenza and influenza viruses in immunocompromised hosts.
Upon completion of her research fellowship, Dr. Mostafa completed a two year Clinical Microbiology Fellowship at the University of Rochester Medical Center (URMC), where she was involved in the implementation of whole genome sequencing in the clinical microbiology laboratory. After her two year fellowship, she became board certified in Medical Microbiology by the American Society for Microbiology.
While large amounts of her work have been presented and published on many topics, her current research interests include genomic surveillance of viruses and the correlation between viral evolution and disease severity. Dr. Mostafa is keen to understand more about the respiratory virome and developing personalized molecular diagnostic panels for immunocompromised populations as well as implementation of innovative molecular diagnostics in the clinical microbiology laboratory.
Currently, she is the Director of Molecular Virology and an Associate Professor of Pathology at Johns Hopkins Medicine where she has been at the forefront of the pandemic, managing routine respiratory pathogen testing for Johns Hopkins and implementation of SARS-CoV-2 testing. In the rapidly evolving diagnostic landscape of 2020, Dr. Mostafa's interests are focused on developing future testing algorithms for respiratory pathogens that include SARS-CoV-2 to continually meet the needs of patient care.
Upon completion of her research fellowship, Dr. Mostafa completed a two year Clinical Microbiology Fellowship at the University of Rochester Medical Center (URMC), where she was involved in the implementation of whole genome sequencing in the clinical microbiology laboratory. After her two year fellowship, she became board certified in Medical Microbiology by the American Society for Microbiology.
While large amounts of her work have been presented and published on many topics, her current research interests include genomic surveillance of viruses and the correlation between viral evolution and disease severity. Dr. Mostafa is keen to understand more about the respiratory virome and developing personalized molecular diagnostic panels for immunocompromised populations as well as implementation of innovative molecular diagnostics in the clinical microbiology laboratory.
Currently, she is the Director of Molecular Virology and an Associate Professor of Pathology at Johns Hopkins Medicine where she has been at the forefront of the pandemic, managing routine respiratory pathogen testing for Johns Hopkins and implementation of SARS-CoV-2 testing. In the rapidly evolving diagnostic landscape of 2020, Dr. Mostafa's interests are focused on developing future testing algorithms for respiratory pathogens that include SARS-CoV-2 to continually meet the needs of patient care.
